YKL-40 as a novel diagnostic biomarker in Toxoplasmosis

被引:5
|
作者
Shahad, Farah Abd AL-Zahra [1 ]
Mohammed, Ahmed A. [1 ]
Jasim, Ghaith Ali [2 ]
机构
[1] Univ Mustansiriyah, Branch Clin Lab Sci, Coll Pharm, Baghdad, Iraq
[2] Univ Mustansiriyah, Branch Pharmacol & Toxicol, Coll Pharm, Baghdad, Iraq
关键词
biomarkers; diagnosis; Toxoplasma gondii; Toxoplasmosis; YKL-40; PREGNANT-WOMEN; GONDII; IMMUNITY; EPIDEMIOLOGY; PATHOGENESIS; IGM;
D O I
10.47750/jptcp.2022.932
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Toxoplasmosis is one of the most globally prevalent zoonotic infection caused by an obligate, intracellular parasite called Toxoplasma gondii. Toxoplasmosis actively triggers an acute immune response and inflammatory reactions, which causes serious pathological changes in various tissues in the human body, and more evidently localizes in different nervous tissues of various body organs. The YKL-40 is a glycoprotein secreted by numerous cell types in different patterns associated with various pathological processes such as inflammatory reactions, tissue remodeling, and fibrosis, and is a disease-specific biomarker of neuroinflammation. Therefore, this study aimed to determine whether the YKL-40 is markedly increased in toxoplasmosis or not and whether its level is different between the acute and chronic phases of the infection to determine if it can be used as a clinically useful biomarker in the diagnosis, and determination of disease severity and follow-up of toxoplasmosis. Accordingly, a total of 80 serum samples were collected from previously diagnosed female patients of different ages with toxoplasmosis. In addition, serum samples of 10 healthy females were used as the control. Patients were first divided into two groups (30 patients with acute infection, and 50 patients with chronic infection) depending on the results of detection of specific anti-Toxoplasma IgM and IgG by enzyme linked immunosorbent assay (ELISA). The level of YKL-40 was then measured in the patients' serum by ELISA. The statistical analysis of data clearly disclosed very highly significant differences (P < 0.001) between the level of YKL-40 in the acute infection group and healthy controls, chronic infection group and healthy controls, and between the groups with acute and chronic infections. These findings led to conclude that YKL-40 classify as a unique and sophisticated biomarker in the diagnosis of toxoplasmosis where it can vitally be used to detect the stage of the disease, whether acute or chronic, besides its ability to detect the infection.
引用
收藏
页码:E61 / E70
页数:10
相关论文
共 50 条
  • [31] Can YKL-40 be an inflammatory biomarker in vitamin D deficiency?
    Can, U.
    Uysal, S.
    Ugur, A. R.
    Toker, A.
    Uysaler, A.
    Hidayetoglu, B. T.
    FEBS JOURNAL, 2016, 283 : 360 - 360
  • [32] Serum YKL-40, a new prognostic biomarker in cancer patients?
    Johansen, JS
    Jensen, BV
    Roslind, A
    Nielsen, D
    Price, PA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (02) : 194 - 202
  • [33] YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
    Xiao, Xin-Qiang
    Hassanein, Tarek
    Li, Qun-Fang
    Liu, Wei
    Zheng, Yu-Huang
    Chen, Jun
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (06) : 605 - 610
  • [34] YKL-40: A Predictive Biomarker for Stage II Colon Cancer
    Arenas, Richard B.
    Swayze-Quinn, Hannah
    Chapman, Christopher N.
    Rosenblum, Frida
    Garb, Jane
    Shao, Rong
    Cao, Q. Jackie
    GASTROENTEROLOGY, 2011, 140 (05) : S997 - S997
  • [35] Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?
    Kastrup, Jens
    IMMUNOBIOLOGY, 2012, 217 (05) : 483 - 491
  • [36] Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis
    Bonella, Francesco
    Long, Xiaoping
    He, Xuan
    Ohshimo, Shinichiro
    Griese, Matthias
    Guzman, Josune
    Costabel, Ulrich
    RESPIROLOGY, 2017, 22 (07) : 1371 - 1378
  • [37] Serum YKL-40 as a novel diagnostic marker for cervical squamous cell carcinoma patients
    Moolmanee, Netchanok
    Limpaiboon, Temduang
    Suwunnapang, Sekson
    Tangsiriwatthana, Thumwadee
    Soponpong, Kanokwan
    Chotiyano, Apinya
    Thumniyom, Sasikarnt
    CANCER SCIENCE, 2018, 109 : 878 - 878
  • [38] Chitinase-3-like protein 1 (YKL-40): novel biomarker of lichen planus
    Khattab, Fathia M.
    Said, Nora M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (09) : 993 - 996
  • [39] Assessment of serum YKL-40 as a diagnostic biomarker and its discriminating power between different liver diseases
    Fahmi, Abdelgawad Ali
    El-Desouky, Mohamed Ali
    Nasraldin, Karima Mahmoud
    BIOSCIENCE RESEARCH, 2018, 15 (04): : 4119 - 4127
  • [40] Novel Inflammatory Marker in Dialysis Patients: YKL-40
    Okyay, Gulay Ulusal
    Er, Ramazan Erdem
    Tekbudak, Merve Yasemin
    Pasaoglu, Ozge
    Inal, Salih
    Onec, Kursad
    Pasaoglu, Hatice
    Altok, Kadriye
    Derici, Ulver
    Erten, Yasemin
    THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 (02) : 193 - 201